CinCor Financial Statements From 2010 to 2024
| CINCDelisted Stock | USD 29.06 0.00 0.00% |
Check CinCor Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CinCor main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . CinCor financial statements analysis is a perfect complement when working with CinCor Pharma Valuation or Volatility modules.
CinCor |
CinCor Pharma Company Shares Outstanding Analysis
CinCor Pharma's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current CinCor Pharma Shares Outstanding | 43.76 M |
Most of CinCor Pharma's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, CinCor Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, CinCor Pharma has 43.76 M of shares currently outstending. This is 75.76% lower than that of the Healthcare sector and 59.04% lower than that of the Biotechnology industry. The shares outstanding for all United States stocks is 92.35% higher than that of the company.
CinCor Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining CinCor Pharma's current stock value. Our valuation model uses many indicators to compare CinCor Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CinCor Pharma competition to find correlations between indicators driving CinCor Pharma's intrinsic value. More Info.CinCor Pharma is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value CinCor Pharma by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for CinCor Pharma's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CinCor Pharma's earnings, one of the primary drivers of an investment's value.About CinCor Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include CinCor Pharma income statement, its balance sheet, and the statement of cash flows. CinCor Pharma investors use historical funamental indicators, such as CinCor Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although CinCor Pharma investors may use each financial statement separately, they are all related. The changes in CinCor Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on CinCor Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on CinCor Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in CinCor Pharma. Please read more on our technical analysis and fundamental analysis pages.
CinCor Pharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of drugs for the treatment for cardio-renal diseases. The company was incorporated in 2018 and is based in Waltham, Massachusetts. Cincor Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 21 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards CinCor Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, CinCor Pharma's short interest history, or implied volatility extrapolated from CinCor Pharma options trading.
Pair Trading with CinCor Pharma
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CinCor Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CinCor Pharma will appreciate offsetting losses from the drop in the long position's value.Moving against CinCor Stock
| 0.73 | BA | Boeing Financial Report 24th of July 2024 | PairCorr |
| 0.63 | VRTX | Vertex Pharmaceuticals Financial Report 6th of May 2024 | PairCorr |
| 0.61 | MCD | McDonalds Earnings Call This Week | PairCorr |
| 0.46 | JNJ | Johnson Johnson Aggressive Push | PairCorr |
| 0.42 | CSLLY | CSL | PairCorr |
The ability to find closely correlated positions to CinCor Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CinCor Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CinCor Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CinCor Pharma to buy it.
The correlation of CinCor Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CinCor Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CinCor Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CinCor Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in CinCor Stock
If you are still planning to invest in CinCor Pharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the CinCor Pharma's history and understand the potential risks before investing.
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |